chartexchange

AKBA
Akebia Therapeutics, Inc.
stockNASDAQ

At CloseNov 13, 2026 3:59:41 PM EST
0.47USD-5.161%(-0.03)3,887,612
Pre-marketNov 13, 2026 9:22:30 AM EST
0.4998USD+0.361%(+0.0018)
After-hoursNov 13, 2026 4:47:30 PM EST
0.4805USD+1.736%(+0.0082)
Loading…
Loading…
131.36M
Healthcare
Biotechnology
CEO
John Butler
HQ
Cambridge, MA, USA
Previous Close
$0.50
Beta
2.48
52-Week High
$1.84 2025-11-17
52-Week Low
$0.36 2026-11-06
SMA 50
$0.78
SMA 200
$1.11
Avg. Vol 10D
8.46M
Avg. Vol 30D
8.79M
Avg. Vol 90D
6.96M
Relative Vol
0.44
277.66M
272.81M
27,204,975
0.4200%
2,000,000
1,314
AKBA Profile

akebia therapeutics, inc. is a biopharmaceutical company headquartered in cambridge, massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (hif) biology. akebia's lead product candidate, vadadustat, is an investigational oral therapy in development for the treatment of anemia related to chronic kidney disease in both non-dialysis and dialysis patients. akebia's global phase 3 program for vadadustat, which includes the pro2tect studies for non-dialysis patients with anemia associated with chronic kidney disease and the inno2vate studies for dialysis-dependent patients, is currently ongoing. for more information, please visit our website at www.akebia.com.

AKBA Performance
PeriodPriceDateChangeBeta
1W0.402026-11-06+17.89%12.812
1M0.772026-10-13-38.56%7.409
3M0.872026-08-13-45.60%5.705
6M1.182026-05-13-59.91%3.578
1Y1.762025-11-13-73.12%2.483
2Y1.922024-11-13-75.36%—
5Y2.872021-11-12-83.52%1.578
AKBA Stock Summary

Akebia Therapeutics, Inc. (NASDAQ:AKBA) stock price today is $0.47, and today's volume is 3,887,612. AKBA is down 5.000% today. The 30 day average volume is 8.79M. AKBA market cap is $131.36M with 277.66M shares outstanding.